NO20050411L - Antiallergisk middel, anvendelse derav for reduksjon av allergi og fremgangsmate for reduksjon av allergi - Google Patents

Antiallergisk middel, anvendelse derav for reduksjon av allergi og fremgangsmate for reduksjon av allergi

Info

Publication number
NO20050411L
NO20050411L NO20050411A NO20050411A NO20050411L NO 20050411 L NO20050411 L NO 20050411L NO 20050411 A NO20050411 A NO 20050411A NO 20050411 A NO20050411 A NO 20050411A NO 20050411 L NO20050411 L NO 20050411L
Authority
NO
Norway
Prior art keywords
antiallergic agent
allergy
allergy reduction
reducing
lactic acid
Prior art date
Application number
NO20050411A
Other languages
English (en)
Norwegian (no)
Inventor
Yuu Ishida
Lzuki Bando
Naoyuki Yamamoto
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Publication of NO20050411L publication Critical patent/NO20050411L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20050411A 2002-06-26 2005-01-25 Antiallergisk middel, anvendelse derav for reduksjon av allergi og fremgangsmate for reduksjon av allergi NO20050411L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002185897A JP4212838B2 (ja) 2002-06-26 2002-06-26 抗アレルギー剤
PCT/JP2003/008094 WO2004002501A1 (ja) 2002-06-26 2003-06-26 抗アレルギー剤、アレルギー低減のためのその使用及びアレルギー低減方法

Publications (1)

Publication Number Publication Date
NO20050411L true NO20050411L (no) 2005-01-25

Family

ID=29996753

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050411A NO20050411L (no) 2002-06-26 2005-01-25 Antiallergisk middel, anvendelse derav for reduksjon av allergi og fremgangsmate for reduksjon av allergi

Country Status (21)

Country Link
US (2) US20050214270A1 (enExample)
EP (1) EP1555028B1 (enExample)
JP (1) JP4212838B2 (enExample)
KR (2) KR100836727B1 (enExample)
CN (1) CN100567489C (enExample)
AT (1) ATE444074T1 (enExample)
AU (1) AU2003246204B2 (enExample)
BR (1) BR0312052A (enExample)
CA (1) CA2490896C (enExample)
DE (1) DE60329516D1 (enExample)
DK (1) DK1555028T3 (enExample)
ES (1) ES2331180T3 (enExample)
MX (1) MXPA04012636A (enExample)
NO (1) NO20050411L (enExample)
PL (1) PL204931B1 (enExample)
PT (1) PT1555028E (enExample)
RU (1) RU2336886C2 (enExample)
TW (1) TW200402304A (enExample)
UA (1) UA86349C2 (enExample)
WO (1) WO2004002501A1 (enExample)
ZA (1) ZA200500715B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1010487A6 (nl) 1996-06-11 1998-10-06 Unilin Beheer Bv Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen.
JP4688457B2 (ja) * 2004-09-10 2011-05-25 四国乳業株式会社 免疫増強組成物
JP4823503B2 (ja) * 2004-10-14 2011-11-24 ジェンモント バイオテック インコーポレイテッド Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍの新規微生物株ＧＭ−０９０、およびＩＦＮ−γ分泌の刺激および／またはアレルギーの処置のためのその使用。
US7351572B2 (en) 2004-10-15 2008-04-01 Genmont Biotech Inc. Microorganism strain GM-090 of Lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy
TW200637908A (en) * 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
KR101260533B1 (ko) 2005-03-03 2013-05-06 가부시키가이샤 메이지 면역기능 조정제
TW200700074A (en) * 2005-03-04 2007-01-01 Calpis Co Ltd Inducer of t cell apoptosis
SI1869161T1 (sl) * 2005-10-11 2010-05-31 Probiotical Spa Postopek za pripravo nealergijskih probiotičnih bakterijskih kultur in ustrezna uporaba
EP1961309A4 (en) 2005-12-06 2010-01-20 Otsuka Pharma Co Ltd EMBRYONIC AXIS FERMENTATION PRODUCT OF SOYBEAN CONTAINING EQUOL, AND METHOD FOR PRODUCING THE SAME
JP5896589B2 (ja) * 2006-10-02 2016-03-30 デュポン ニュートリション バイオサイエンシーズ エーピーエス 疾病の罹患率及び持続期間を減少する使用のためのプロバイオティクス
AU2007335423B2 (en) 2006-12-21 2012-09-13 Calpis Co., Ltd. IgA production promoter
CN101796187A (zh) 2007-07-04 2010-08-04 龟甲万株式会社 乳酸菌来源的双链rna
RU2431663C2 (ru) * 2008-01-28 2011-10-20 Общество с ограниченной ответственностью "ИнноПроб" (ООО "ИнноПроб") ИММУНОБИОЛОГИЧЕСКОЕ ПРОТИВОАЛЛЕРГИЧЕСКОЕ СРЕДСТВО (ВАРИАНТЫ) И ШТАММ Lactobacillus acidophilus 100 аш ПА, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПРОИЗВОДСТВА ИММУНОБИОЛОГИЧЕСКОГО ПРОТИВОАЛЛЕРГИЧЕСКОГО СРЕДСТВА
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
RU2393214C1 (ru) * 2009-01-29 2010-06-27 Общество с ограниченной ответственностью "ИнноПроб"(ООО"ИнноПроб") Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus nkjc, штамм lactobacillus acidophilus jch, штамм lactobacillus acidophilus kaa
RU2460781C2 (ru) * 2009-01-29 2012-09-10 Общество с ограниченной ответственностью "ИнноПроб" (ООО "ИнноПроб") Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus, используемый при приготовлении иммунобиологического противоаллергического средства
EP2332557A1 (en) 2009-12-08 2011-06-15 Campina Nederland Holding B.V. Probiotic lactic acid bacteria
TW201300526A (zh) * 2011-03-25 2013-01-01 Calpis Co Ltd 培養基之製造方法及該方法所製造之培養基
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
EP2799069A4 (en) 2011-12-28 2015-12-23 Maruha Nichiro Corp DEGRANULATION INHIBITOR WITH CHLOROPHYLL C
JP6149228B2 (ja) * 2013-04-11 2017-06-21 アサヒグループホールディングス株式会社 免疫調節作用を有する乳酸菌のスクリーニング方法
JP5927730B2 (ja) 2013-04-11 2016-06-01 アサヒグループホールディングス株式会社 免疫調節作用を有する乳酸菌のスクリーニング方法
KR101688224B1 (ko) * 2015-05-01 2016-12-20 일동바이오사이언스(주) 관절염 예방 및 치료 효과를 갖는 아이디-씨비티5101(id-cbt5101) 및 이의 용도
CA3023867A1 (en) * 2016-05-09 2017-11-16 Biogaia Ab Selection of bacterial strains useful in allergy treatment
EP3511409A4 (en) 2016-09-12 2020-05-06 Ichibiki Co Ltd. SALT-TOLERANT LACTOBACILLA, SALT-TOLERANT LACTOBACIL CULTURE AND IMMUNOSTIMULATOR
SG11202005863TA (en) 2018-01-12 2020-07-29 Gi Innovation Inc Composition comprising probiotics and polypeptide having binding affinity for ige and use thereof
JP2021059522A (ja) * 2019-03-20 2021-04-15 キユーピー株式会社 アレルギー症状改善用組成物
CN116035187B (zh) * 2022-12-30 2025-02-07 江南大学 一种使用植物乳杆菌发酵降低苦杏仁蛋白致敏性的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US575270A (en) * 1897-01-12 Combined cover and stand for books
US635796A (en) * 1898-03-07 1899-10-31 Isaac Moore Manifolding sales-book.
US959766A (en) * 1909-05-14 1910-05-31 Lewis Life Wire-fastener.
US1048383A (en) * 1911-06-16 1912-12-24 Charles J Carroll Manifolding sales-book.
US1201377A (en) * 1916-07-24 1916-10-17 William S Staiars Protector-tablet.
US1915974A (en) * 1930-07-10 1933-06-27 American Sales Book Co Ltd Retaining device
US2218297A (en) * 1936-07-14 1940-10-15 Randzio Reinhold Bookkeeping system
US2806715A (en) * 1956-06-29 1957-09-17 Henry O Smith Illuminated note pad holder
JPH0634709B2 (ja) * 1985-12-03 1994-05-11 カルピス食品工業株式会社 新規乳酸菌
US4787852A (en) * 1987-04-24 1988-11-29 Melnick David W Multicolor interactive notepad
US4840406A (en) * 1987-05-29 1989-06-20 Dennison Manufacturing Company Method of mounting index tabs upon stenographic notebooks
US4816884A (en) * 1987-07-20 1989-03-28 International Business Machines Corporation High density vertical trench transistor and capacitor memory cell structure and fabrication method therefor
WO1995014485A1 (en) * 1993-11-23 1995-06-01 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
CN1110147A (zh) * 1994-04-09 1995-10-18 山田武敏 抗变态反应组合物
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP4064480B2 (ja) * 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 ＩｇＧ抗体産生抑制剤
JPH10309178A (ja) * 1997-05-09 1998-11-24 Wakamoto Pharmaceut Co Ltd ビフィズス菌を有効成分とする抗アレルギー剤および醗酵食品
USD393841S (en) * 1997-05-27 1998-04-28 Fujitsu Limited Renewal of document to make alterations icon for a display screen
US6657642B1 (en) * 1997-07-03 2003-12-02 International Business Machines Corporation User interactive display interfaces with means for interactive formation of combination display objects representative of combined interactive functions
JP2000086524A (ja) * 1998-09-05 2000-03-28 Shadan Seirankai 生きた腸内細菌を含有する抗アレルギー剤
JP2000095697A (ja) * 1998-09-18 2000-04-04 Advance Co Ltd 抗アレルギー剤
JP2000239175A (ja) * 1999-02-18 2000-09-05 Calpis Co Ltd 抗アレルギー剤
US6217443B1 (en) * 1999-03-11 2001-04-17 Leonard C. Green, Jr. Carbonless paper notepad
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
GB2365659B (en) * 2000-02-25 2002-07-24 Red Fig Ltd Serving hypermedia documents
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
SI1312667T1 (sl) * 2000-08-25 2009-04-30 Wakamoto Pharma Co Ltd Probiotiäśni produkti, ki vsebujejo sev l. salivarius
US20030021624A1 (en) * 2001-06-29 2003-01-30 Dorsey Cheryl L. Article and method for making a notebook with permanent and disposable elements
DE20202562U1 (de) * 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika

Also Published As

Publication number Publication date
TWI304736B (enExample) 2009-01-01
JP2004026729A (ja) 2004-01-29
CN1678330A (zh) 2005-10-05
EP1555028A4 (en) 2007-06-06
CA2490896A1 (en) 2004-01-08
CN100567489C (zh) 2009-12-09
PT1555028E (pt) 2010-01-05
PL204931B1 (pl) 2010-02-26
ZA200500715B (en) 2006-08-30
RU2336886C2 (ru) 2008-10-27
AU2003246204A1 (en) 2004-01-19
TW200402304A (en) 2004-02-16
DK1555028T3 (da) 2010-02-01
ATE444074T1 (de) 2009-10-15
US8003092B2 (en) 2011-08-23
EP1555028A1 (en) 2005-07-20
DE60329516D1 (de) 2009-11-12
KR20050014879A (ko) 2005-02-07
US20090047264A1 (en) 2009-02-19
KR100836727B1 (ko) 2008-06-10
ES2331180T3 (es) 2009-12-23
EP1555028B1 (en) 2009-09-30
US20050214270A1 (en) 2005-09-29
AU2003246204B2 (en) 2007-07-12
CA2490896C (en) 2011-02-01
WO2004002501A1 (ja) 2004-01-08
HK1081432A1 (zh) 2006-05-19
MXPA04012636A (es) 2005-03-23
JP4212838B2 (ja) 2009-01-21
UA86349C2 (ru) 2009-04-27
KR20080018287A (ko) 2008-02-27
RU2005101766A (ru) 2005-08-20
PL375158A1 (en) 2005-11-28
BR0312052A (pt) 2005-03-29

Similar Documents

Publication Publication Date Title
NO20050411L (no) Antiallergisk middel, anvendelse derav for reduksjon av allergi og fremgangsmate for reduksjon av allergi
EP1634600A4 (en) ANTIALLERGIC COMPOSITION
ATE439138T1 (de) Probiotika zur primären prävention atopischer erkrankungen
DE60222238D1 (de) Zusammensetzung und verfahren zur perkutanen superoxygenierung
DE60211891D1 (de) Carbonsäure-substituierte oxazol-derivate zur verwendung als ppar-alpha und -gamma aktivatoren zur behandlung von diabetes
WO2006084210A3 (en) Hif modulating compounds and methods of use thereof
SI2277524T1 (sl) Zdravljenje sindroma razdražljivega črevesja z uporabo probiotičnih bakterij in fermentiranih žit kot efektorjev zdravljenja
DE60316772D1 (de) Von menschen oder tieren verwenbare diätetische und/oder pharmazeutische zubereitungen, auf basis von probiotischen mikroorganismen
NO20092227L (no) Salter og krystallformer av 2-metyl-2-[4-(3-metyl-2-okso-8-konolin-3-yl-2,3-dihydro-imidazo[4,5-C]kinolin-1-yl)-fenyl]-propionitril
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
AU2006253006A8 (en) Feline probiotic Lactobacilli
ATE336996T1 (de) Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem
NO20065536L (no) Behandling av astma hos barn
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
ATE537837T1 (de) Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung
ATE402924T1 (de) Pyridiniumsalze und deren verwendung
TW200700074A (en) Inducer of t cell apoptosis
ATE464045T1 (de) Zusammensetzung aus milchsäure und lactoferrin
ATE386513T1 (de) Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie
NO20062639L (no) Bicykliske pyraxoloncytokininhibitorer
DE602004027384D1 (de) Benzofuranderivate und deren verwendung bei der behandlung von mikrobiellen infektionen
NO20060095L (no) Celler anvendt som baerere for bakterier
ATE390144T1 (de) Behandlung von fibrosen
AU2003240254A1 (en) Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac
Fisher Interview: The halitosis guru

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application